Various funding agencies, levels of patients, caregiver and stakeholder engagement, and potential benefits
| Funding agency . | Level of engagement . | Benefits . |
|---|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | Desirable | Possibly beneficial |
| Center for Medicare and Medicaid Services (CMS) Innovation Center | Required | Beneficial |
| National Institutes of Health (NIH) | Potentially advantageous | Possibly beneficial |
| Patient-Centered Outcomes Research Institute (PCORI) | Expected | Beneficial |
| Pharmaceutical companies (industry) | Potentially advantageous | Beneficial |
| Professional societies and organizations | Desirable | Possibly beneficial |
| Funding agency . | Level of engagement . | Benefits . |
|---|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | Desirable | Possibly beneficial |
| Center for Medicare and Medicaid Services (CMS) Innovation Center | Required | Beneficial |
| National Institutes of Health (NIH) | Potentially advantageous | Possibly beneficial |
| Patient-Centered Outcomes Research Institute (PCORI) | Expected | Beneficial |
| Pharmaceutical companies (industry) | Potentially advantageous | Beneficial |
| Professional societies and organizations | Desirable | Possibly beneficial |
Note: Level of engagement is defined as the depth and the extent to which patients, caregivers, and stakeholders are engaged in different stages of a given research project that is proposed for funding by any of the listed agencies.